Use access key #2 to skip to page content.
$0.72 -0.09 (-11.11%)
10/10/2008 3:55 PM

Labopharm, Inc. (DDSS)

CAPS Rating:
*

An international, specialty pharmaceutical company focused on improving existing drugs by incorporating its proprietary, advanced controlled-release technologies.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

DDSS doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

43 Outperforms
13 Underperforms
 

All-Stars

5 Outperforms
6 Underperforms
 

Wall Street

2 Outperforms
0 Underperforms
 

Members bullish on DDSS are also bullish on:

Members bearish on DDSS are also bearish on:

Ticker Tags

Micro Cap (4824), Drug Related Products (25)
Suggest a tag

Labopharm, Inc. At A Glance

Current Price: $0.72
Last Trade Time: 10/10/2008 3:55 PM
Open: $0.73
Previous Close: $0.81
Daily Range: $0.66 - $0.81
52-Week Range: $0.63 - $3.04
Volume: 27,000
Market Cap: $46.03M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

DDSS VS S&P 500 (SPY)

DDSS 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for DDSS

More Headlines...

Top Bull Pitch

Recs

1

Labopharm, Inc. (DDSS)

Avatar alocemar (30.06) Submitted: 9/06/07 8:15 PM

Distribution of Tramadol products in most of the country...(but USA).


Lot of cash at the bank will allow them to better distribuate their products.


Product (Trazodone)under development (phase III) to be distributed the same way Tramadol is. It's a 13 Billion market.

More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Labopharm, Inc. (DDSS)

Avatar msamet1 (97.83) Submitted: 3/30/07 10:40 AM

Drug delivery and reformulation is a crowded sector and requires branded life cycle extensions for strategies to be profitable

Replies: 4 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 11 :   1 2 3 Next »

Recs

0

 (DDSS)

Avatar zzlangerhans (98.66) Submitted: 5/05/08 1:11 PM : Outperform Start Price: $1.98 DDSS Score: -26.49

With a 100M market cap and the enormous markets of pain and depression of which they stand at the threshold, Labopharm is essentially priced as a con job a la Hemispherx or Introgen. And indeed they may be, but I can't find any evidence for it. Recent news on once-daily Tramadol has been mixed, but momentum seems to be in the company's favor and it seems very likely that this very safe pain medication will eventually be approved. The positive results of the phase III trial of once-daily trazodone did not stimulate an appropriate rise in stock price. And the company now has a third product, twice-daily tramadol/acetaminophen, in phase III. With a lot of major potential short-term catalysts, 2008 should be a very interesting year for Labopharm.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (DDSS)

Avatar emill1 (36.70) Submitted: 4/16/08 5:33 PM : Outperform Start Price: $1.98 DDSS Score: -28.62

will get fda approval

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (DDSS)

Avatar enddreams1 (< 20) Submitted: 2/15/08 7:33 AM : Underperform Start Price: $2.91 DDSS Score: 41.03

the stock is moving up first target 3.80 once is over 3.80 5.77 than see 7

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (DDSS)

Avatar steelpoker (< 20) Submitted: 2/09/08 3:33 PM : Outperform Start Price: $2.53 DDSS Score: -38.03

Going to go up more... (owned it before, forgot to add it in here)...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (DDSS)

Avatar Stueyh1122 (37.16) Submitted: 1/30/08 11:18 AM : Outperform Start Price: $2.06 DDSS Score: -30.21

FDA olive branch shows light at the end of the tunnel for DDSS.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 11 :   1 2 3 Next »

Wall Street

Results 1 - 2 of 2  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRBCCapMkts 84.11 02/22/07 Outperform NS $6.18-88.35%-39.45%-48.90
TrackWedbush 61.41 02/14/07 Outperform NS $6.10-88.20%-39.14%-49.05

Results 1 - 2 of 2  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners